Rodrigo Assar: We Are Pushing the Boundaries by Using Computational Approaches
Rodrigo Assar, Senior Data Scientist at Globant, shared a post on LinkedIn:
”Milestone Alert! Modeling the Unseen Forces of Blood!
Thrilled to share some fantastic news about our Research Topic in Frontiers in Cardiovascular Medicine: “Innovative Modeling and Simulation in Thrombosis and Hemostasis: Enhancing Diagnosis and Treatment”! Frontiers
Co-edited with Daria Hemmerling, PhD, we’ve hit 6 published articles and have several more cooking in the lab!
Why does this matter? Understanding hemostasis—that delicate balance keeping our blood flowing smoothly yet ready to clot when needed—is vital. Imbalances lead to strokes and heart attacks. That’s where the magic of mathematical modeling comes in!
We are pushing the boundaries by using computational approaches to simulate platelet activation, coagulation dynamics, and vascular responses. Our goal? To move beyond observation and start predicting thrombotic risks and developing truly tailored treatments.
If you are working on cutting-edge mathematical or computational models related to thrombosis, hemostasis, or diagnostic enhancement, we want to hear from you! This is the perfect venue to showcase your high-impact work.
Don’t miss out! Check out the details and submit your manuscript here.
Let’s enhance diagnosis and treatment together!”
Find similar posts on Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia